Navigation Links
Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
Date:4/15/2008

ng statements. Such forward-looking statements include statements about the ability of Iomai's adjuvant patches to provide protective immune responses with one or two doses of H5N1 influenza vaccine; the significance of the results described in this press release to government health officials in addressing an outbreak of pandemic influenza; that the clinical trial data from the new clinical trial will be sufficient to proceed next with a pivotal Phase 3 clinical trial; that the characteristics of Iomai's adjuvant patch described in this press release would make the product ideal for stockpile and rapid distribution; the anticipated reimbursement for the costs associated with further testing of the adjuvant the patch and the potential future funding authorized by HHS. Applicable risks and uncertainties include, among others, that future clinical trials may not replicate results seen in the trial described in this press release; that the U.S. Food and Drug Administration or other regulatory authorities may not concur with Iomai's analysis of the trial results described in this press release; that Iomai may not be able to enroll sufficient numbers of subjects in future clinical trials; that Iomai may be unable to obtain the regulatory approvals or financing necessary to conduct additional clinical trials, or to develop the product to a point where the adjuvant patch can be sold to the government for stockpiling for its pandemic influenza program; that competitors may develop products that are safer, more effective, or more convenient to use; future clinical results may not support regulatory approval to commercialize Iomai's adjuvant patch for pandemic influenza applications, which will depend on the outcome of additional clinical trials and analysis by regulatory authorities of data Iomai submits; that Iomai may not meet its contractual milestones in order to fully perform under the contract and thereby receive complete reimbursement from HHS; that Congress will not
'/>"/>
SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
3. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
4. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
5. Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
6. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
7. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
9. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
10. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
11. CryoCor Receives FDA Approval for Right Atrial Flutter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... LOUIS , Nov. 26, 2014 Scott Steiger ... seen most of the world. As an engineer for the past ... a member of the military service. He,s been to six of ... Photo - http://photos.prnewswire.com/prnh/20141126/161076 Photo - ... specifically for travelers, he has a pretty good idea of what,s ...
(Date:11/26/2014)... November 26, 2014 A hernia is ... organ protrudes through the wall of a weak muscle area. ... birth are some of the causes of hernias. There are ... and incisional. An inguinal hernia is when part of the ... is found in the area of the umbilicus. A hiatal ...
(Date:11/26/2014)...  CARsgen, a leader in the development of Chimeric ... variety of cancers, today announced the completion of a ... China -based healthcare private equity fund.   ... development of new therapeutics for liver, lung, stomach and ... Shanghai Renji Hospital, the company plans to initiate clinical ...
Breaking Medicine Technology:Steiger Has Created the First Pill Case Specifically Designed For Travel 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4CARsgen Completes Series A Financing 2
... Possible by Early Investment by Cystic Fibrosis ... ... Gilead Sciences,Inc., one of the world,s largest biopharmaceutical companies, and Parion,Sciences, ... a compound that could become an important,new drug in treating the ...
... DIEGO, Aug. 16 ADVENTRX Pharmaceuticals,Inc. (Amex: ... development company,focused on commercializing proprietary product candidates ... today announced that the U.S. Food and,Drug ... for ANX-510,or CoFactor(R) injection, which is currently ...
Cached Medicine Technology:Promising Cystic Fibrosis Compound on Track for Development 2ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer 2ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer 3
(Date:11/27/2014)... HealthDay Reporter , WEDNESDAY, Nov. 26, 2014 (HealthDay ... second language, new research suggests. But anyone who tries to ... boost, the small study finds. The brain "becomes ... Li, co-director of the Center for Brain, Behavior and Cognition ... said, that "the brain networks of the more successful learners ...
(Date:11/27/2014)... 27, 2014 In order to enable people ... Fla., designed an easy way to avoid touching a toilet ... then created a prototype of the patent-pending Toilet Tamer, a ... toilet seat and/or lid in a more sanitary manner. It ... of germs. Overall, it promotes good hygiene and peace of ...
(Date:11/27/2014)... New York (PRWEB) November 27, 2014 ... individuals who were allegedly injured by the medication are ... a federal litigation is looking ahead to a status ... According to a Scheduling Order issued earlier this year, ... on December 16th at 10:00 a.m. Items likely to ...
(Date:11/27/2014)... “LAB.C” was featured on NewsWatch as part ... coolest technology products available to consumers. Mallory Sofastaii, a technology ... and shared with viewers the company offers a cable ... , Consumers love portability and functionality. A unique mobile ... the iPhone5 and 5S has a portable USB charger built ...
(Date:11/27/2014)... 27, 2014 HealthPostures, a ... equipment , has announced that it has entered ... Environments. The partnership will put HealthPostures' products into ... , In addition to having its products sold ... promotes HealthPostures' products with the business decision makers ...
Breaking Medicine News(10 mins):Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2
... KINGSTON, R.I. -October 27, 2009Two University of Rhode Island ... discovered a technology that can detect cancerous tumors and ... cells surrounding them, thereby significantly reducing side effects. The ... grants in four years. In addition, a number of ...
... developing a range of miniaturised wearable and track-side sensors, ... British athletes improve their performance on the world stage, ... will be officially launched tomorrow (28 October 2009). ... Sensing (ESPRIT) project is funded by the EPSRC and ...
... less of a mystery, study finds. , TUESDAY, Oct. 27 ... the progression of cancer by stimulating a pathway inside cells. ... treatment of cancer, which has been linked to alcohol use ... connected to colon and breast cancer, although it,s not known ...
... N.C., Oct. 27 In conjunction with National Respiratory Care ... support and comfort industry, is proud to promote the results ... with CPAP patients daily. One of the most common ... their CPAP mask, as a result of the mask pressing ...
... SAN DIEGO, Oct. 27 Amira ... discovery and early development of new drugs to treat inflammatory ... present a company overview at the 8th Annual BIO Investor ... on Thursday, October 29, at the Palace Hotel in San ...
... Reform Included in Health Care Reform Le g ... meaningful medical liability reform and agree that changes to our ... care reform legislation passed by the Congress, according to a ... and Access. , "The HCLA poll clearly shows that ...
Cached Medicine News:Health News:URI research couple's method targets cancerous tumors 2Health News:URI research couple's method targets cancerous tumors 3Health News:URI research couple's method targets cancerous tumors 4Health News:Major research collaboration will improve British athletes' performance on world stage 2Health News:Major research collaboration will improve British athletes' performance on world stage 3Health News:Mapping the Link Between Alcohol, Cancer 2Health News:Contour Products Promotes Survey for National Respiratory Care Week, Findings Prove Benefits of Contour CPAP Pillow for Sleep Apnea Patients 2Health News:Contour Products Promotes Survey for National Respiratory Care Week, Findings Prove Benefits of Contour CPAP Pillow for Sleep Apnea Patients 3Health News:New Poll Shows Americans Want Medical Liability Reform 2
... of treating upper extremity fractures with ... many studies. , ,Intramedullary nailing using ... offers the benefits of anatomic alignment, ... dissection and early rehabilitation of the ...
... An innovative new system to help you ... The system's one-piece design creates a ... enhances postoperative radiographic assessment. The slotted superior ... the central column and are flared outward ...
... The QuickSite model 1056K LV lead ... and to promote shorter procedure times, ... performance, and reliability., ,The QuickSite LV ... advanced left ventricular lead, including such ...
... The AIM Titanium Tibial Nail ... the mechanical failures of existing ... for tibial interlocking nails. It ... range of diameters and lengths ...
Medicine Products: